期刊文献+

药物中磺酸酯类基因毒性杂质研究进展 被引量:18

Advances on genotoxic impurities of sulfonate esters in pharmaceuticals
下载PDF
导出
摘要 该文概述了近10年来有关药物中基因毒性杂质监管指南的完善历程与相关检测方法的研究进展。介绍了基因毒性杂质从早期的完全避免到目前的阶段化毒理学关注阈值(TTC)的风险控制理念以及各主流监管机构的具体要求。作为一类重要的基因毒性杂质,磺酸酯主要来源于磺酸及衍生物与低级醇(如甲醇、乙醇、异丙醇等)之间发生的副反应,具有化学结构类型多样化的特点。该文较为详尽地介绍了磺酸酯的形成机理和文献所采用的液相色谱法和气相色谱法,并对色谱方法的选择、预处理方式、衍生化方法及相应痕量水平的灵敏度和回收率等进行了评述。由此期望为合理控制药物中磺酸酯类基因毒性杂质,为保证药物的质量安全性提供有益的指导意见。 This article reviews the refinement of regulatory guidelines and progress of research on the control of genotoxic impurities in pharmaceuticals in the last decade. It outlines advances in the regulatory requirements for genotoxic impurities from strict avoidance to the currently accepted concept of threshold of toxicological concern (TTC), which is based on risk control considerations. Specific control limits, which are required by predominant administrative regulatory agencies, such as U. S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and the international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH), etc. Sulfonate esters, an important class of potential genotoxic impurities, are usually generated by side-reactions between sulfonic acids or their derivatives and relative low molecular mass alcohols, such as methanol, ethanol, and isopropanol. The resulting sulfonate esters are characterized with diverse chemical structures. Reaction mechanisms of the formation of sulfonate esters and various strategies to control them have been schematically described. A detailed summary has been given for the analytical methodology developed using high performance liquid chromatography (HPLC) and gas chromatography (GC) to determine trace amounts of sulfonate esters in pharmaceuticals. Furthermore, we have comprehensively discussed the options for the chromatographic methods, sample pretreatments, and derivatization methods, as well as each method's sensitivity and recovery at trace level. This review intended to provide constructive suggestions for the rational control of sulfonate esters in pharmaceuticals to ensure their clinical safety.
作者 刘雪薇 厉程 韩海云 张文鹏 陈东英 LIU Xuewei;LI Cheng;HAN Haiyun;ZHANG Wenpeng;CHEN Dongying(Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Shanghai Center for Drug Evaluation and Inspection,Shanghai 201203,China)
出处 《色谱》 CAS CSCD 北大核心 2018年第10期952-961,共10页 Chinese Journal of Chromatography
基金 中国科学院药物创新研究院自主部署科研项目(CASIMM0120163011)~~
关键词 基因毒性杂质 磺酸酯 控制策略 色谱方法 综述 genotoxic impurity sulfonate ester control strategy chromatographic method review
  • 相关文献

参考文献7

二级参考文献52

  • 1姚继红,苏成业,储晓岩.长春西汀在大鼠体内的药代动力学及生理处置[J].药学学报,1994,29(2):81-85. 被引量:6
  • 2聂淑芳,潘卫三,李伟,杜玍妮.长春西汀的大鼠在体肠吸收研究[J].中国医药工业杂志,2005,36(10):625-628. 被引量:21
  • 3梁美好,沈正荣.(+)-氯吡格雷的合成工艺改进[J].中国药物化学杂志,2007,17(3):163-165. 被引量:12
  • 4Sitaram C, Rupakula R B. Determination of alkyl methanesulfonates in doxazosin mesylate by gas chromatography-mass spectrometer [J]. Indian J Pharm Sci, 2011, 73(1): 107-110.
  • 5Garcia A, Rup6rez F J, Ceppa F, et al. Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate [J]. JPharm BiomedAnal, 2012, 61: 230-236.
  • 6European Medicines Agency. Evaluation of medicines for human use guideline on the limits of genotoxic impurities[EB/OL].[2014-01-27] http://www.rsihata.com/updateguidance/emeaJold/519902en.pdf.
  • 7ICH Q3A (R2), Impurities in New Drug Substances[ EB/OL]. (2006 - 10-25). [2014 -03 -31]. http://www, ich. org/ LOB/media/MEDIA422. pdf.
  • 8ICH Q3B (R2) Impurities in New Drug Substances [ EB/OL]. (2006 -06-02). [2014 -03 -31]. http://www, ich. org/ LOB/media/MEDIA421. pdf.
  • 9ICH Q3C ( R3 ) Impurities: Guideline for Residual Solvents [EB/OL]. (2005-11). [2014 -03 -31]. http://www, ieh. org/LOB/media/MEDIA423, pdf.
  • 10EMEA. Guideline on the limits of Genotoxic hnpurities [ EB/OL]. (2006 -06 - 28). [2014 -03 -31]. http://www. emea. europa, eu/pdfs/human/swp/519902en, pdf.

共引文献131

同被引文献219

引证文献18

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部